HGI-498

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameHGI-498

Drug Alias NameHGI498

ClassificationBiologics > Oncolytic virusCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Vesicular stomatitis virus vectorBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)

Mechanisms of ActionAnti-Glypican-3

TargetsGlypican-3

Therapy Area/IndicationsLiver Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHumane Genomics Inc

China Registration ClassN/A

Develop Information

Active CompaniesHumane Genomics Inc

Inactive CompaniesN/A

Active IndicationsLiver Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A